chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had reactions after the first shot of Pfizer-BioNTech on 01/27/2021, but did not think it was related to the vaccine. I felt pulsing and throbbing in my legs- but I thought it was related to my arthritis. I had COVID from March 14, 2020 through April 20th, 2020. I tested positive for antibodies on June 23rd, 2020. I had gotten a steroid shot in my right knee 12/10/2020 because I experienced some inflammation- the result of this was positive- I moved around easily through 12/25/2020 into the New year of 2021 and most of January. On January 27, 2021, I received my first Covid vaccine. A day later I had unusual inflammation of my right knee- I could hardly bend it. I walk down & up 80 steps everyday total (160)
suspected vaccination failure/I got my two shots and years ago I had Shingles; shingles, bad; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient did not care he/she got two Shingles shots and four years ago from reporting date, had shingles. The patient stated shingles was so bad that the patient did not want them again. This case was considered as suspected vaccination failure as details regarding the time to onset and laboratory test confirmation for shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Information has been received from a physician concerning his sister, a 20 year old female with a history of dysmenorrhoea who on approximately 03-JAN-2008 was vaccinated with her first dose of Gardasil.  Concomitant therapy included hormonal contraceptives (unspecified).  Twelve or thirteen days after vaccination, the patient experienced dizziness and almost passed out.  The patient sought unspecified medical treatment by contacting her brother who is a physician.  The patient has been in and out of the emergency room because of the dizziness.  A CBC, CT scan, and urinalysis were performed and all were normal.  The patient received the vaccine from her pediatrician, so no further information is available.  The patient is still experiencing the severe dizziness.  Additional information has been requested.
The patient was given the original Pfizer grey cap as a booster instead of the Pfizer Bivalent grey cap.  The technician accidentally handed me, the pharmacist, the wrong vile and they look identical except for the description, which is in very small font.  We did not realize until afterwards when trying to batch fill the rx for the vaccine.  We were unable to reach the patient after many attempts by phone.  Recommendation would be to vaccinate with the Pfizer Bivalent 2 months from date 11/08/22.   No known adverse reactions occurred from the Vaccine administration error.
Employee began to have difficulty swallowing after receiving the H1N1  LIVE Intranasal Vaccine. Became gradually worse. Color pale, BP and P were normal.  Could speak, but  stated her throat felt like it was swelling. She was given one dose of an EPIPEN with good results at 3:00 pm. Monitored and sent home for the day stayed home the next day but returned on Friday the 11/20/2009 with no complaints.
Information has been received from a registered nurse referring to a patient of unknown age and gender on 20-OCT-2017. There was no information about patient's concurrent conditions, medical history or concomitant medications. On 15-SEP-2017, the patient was vaccinated with improperly stored VARIVAX lot # N012131 and expiration date of 17-APR-2019, (route of administration and anatomical location were not reported) for prophylaxis, reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (lot # unknown), The vaccines were stored in the range of 6 Farenheit degrees to 14 Farenheit degrees for 3 hours and 40 minutes. No previous temperature excursion was reported. The patient did not experience any adverse events. Digital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1709USA007342: US-009507513-1710USA014743: US-009507513-1710USA014744: US-009507513-1710USA014746: US-009507513-1710USA014747: US-009507513-1710USA014748: US-009507513-1710USA014749:
I am not sure which RSV vaccine I received.  In almost exactly two hours, I started uncontrollable sneezing and runny nose.  I had absolutely no symptom prior to that.  The symptoms remained mild for 4 days or so and then began to be very uncomfortable--full blown respiratory issues.  I was prescribed amoxicillin and felt better a week and one day later.  I had mild asthma symptoms and used an albuterol inhaler a few times in the course of the illness.  Today I still have mild coughing and congestion.  The nurse practitioner I spoke with maintained the timing of the vaccine and the onset of symptoms must have been coincidental, but I wonder.
she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive; she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive; she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive) and RASH (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive) and RASH (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive). At the time of the report, FEELING HOT (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive) and RASH (she had a Moderna shot she broke out in a bad rash and got very hot and could not even drive) outcome was unknown.            Patient was age was reported as between the ages of 20 and 30.  Concomitant product use was not provided by the reporter.  Suspect vaccine dosage text was reported as unknown.  It was reported that pharmacist told the reporter about Six months ago, she had a female patient come into the pharmacy had the reaction when patient last time took the moderna shot. Patient did not take the moderna shot from the same pharmacy.  Treatment information was not provided.
some labs that are 1 point outside of the normal range; second dose of Prevnar 20 vaccine was given to a patient; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team,.  An 80-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 31Jan2023 at 09:38 as dose 2, 0.5 ml single (Lot number: GL3699, Expiration Date: 31Jul2024) at the age of 80 years, in right deltoid for immunisation. The patient's relevant medical history included: "Pancreatic mass"; "stage 3 chronic kidney disease"; "Dermatitis"; "nodule of middle lobe of right lung"; "overweight", start date: 06Sep2022, notes: BMI 25-29; "Covid 19", start date: 04Jan2023; "acute cystitis", start date: 06Jan2023; "hematuria", start date: 06Jan2023; "obstructive sleep apnea on CPAP", notes: Obstructive sleep apnea on CPAP; "GERD"; "coronary artery disease"; "Mixed hyperlipidemia"; "Anxiety"; "type 2 diabetes"; "insomnia due to medical condition"; "coronary bypass graft of native heart without angina pectoris"; "CPAP". The patient's medical history, reported also as family history: "Primary hypertension". Concomitant medication(s) included: NEXIUM [ESOMEPRAZOLE SODIUM] oral taken for gastrooesophageal reflux disease (ongoing); AMLODIPINE oral taken for essential hypertension (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] oral taken for coronary artery disease (ongoing); ATORVASTATIN oral taken for type v hyperlipidaemia, start date: 14Aug2017 (ongoing); BUSPIRONE oral taken for anxiety, start date: 16Apr1021 (ongoing); CHLORTHALIDONE oral taken for essential hypertension, start date: 27Aug2022 (ongoing); Q10+VIT.E, start date: 12Sep2017 (ongoing); GLIPIZIDE oral taken for type 2 diabetes mellitus, start date: 05Sep2017 (ongoing); LOSARTAN oral taken for essential hypertension, start date: 16Apr2021 (ongoing); METOPROLOL TARTRATE oral taken for essential hypertension, start date: 01Jul2017 (ongoing); JANUVIA oral taken for type 2 diabetes mellitus, start date: 15Jun2022 (ongoing); ZOLPIDEM oral taken for sleep disorder due to a general medical condition, start date: 15Aug2017 (ongoing). Vaccination history included: prevnar 13, administration date: 20Jul2018, for immunisation; prevnar 20 (DOSE 1, lot number: FW2328, 0.5 ml in left arm), administration date: 15Sep2022, for immunisation. The following information was reported: INCORRECT DOSE ADMINISTERED (non-serious) with onset 31Jan2023 at 09:38, outcome "unknown", described as "second dose of Prevnar 20 vaccine was given to a patient"; LABORATORY TEST ABNORMAL (non-serious), outcome "unknown", described as "some labs that are 1 point outside of the normal range". Relevant laboratory tests and procedures are available in the appropriate section.
pt recv vax; devel rash on abd, lasted 24-72 hr; since then severe joint pains inc in intensity;motrin given;no swelling noted of ankles; pain in knees,ankles,neck ,back & shoulders; tx w/ bed rest, naprosyn;
Redness at injection site, swelling of arm from shoulder to elbow crease, itching, tenderness on arm, under arm, above breast, around back.
Mother reports: one week after his shots, pt had a 102 F fever and hives, red raised itchy rash on chest and legs and arms. She gave her son Tylenol and Benadryl for 2 days. The symptoms resolved.
15-20 minutes after being vaccinated employee started to feel funny and head started spinning. BP 193/80. Transported to ER.Given script for Meclizine.
A report was rec'd from a hlth professional on 1/30/02 regarding a female pt who experienced injection site reaction, acute viral illness and arm weakness which was considered disabling after receiving a Fluvirin vaccine in 10/01. The pt has had a previous influenza vaccination (brand not specified). In 10/01 the pt rec'd a Fluvirin vaccine and was on an unknown date experienced painful arm at injection site which resolved. Two months later the pt had an acute viral illness which included swollen glands. The pt's arm also became swollen and painful, her arm still remains painful especially around the site of vaccination. The pt feels her arm is weaker and is receiving physical therapy treatment. The pt had not recovered at the time of reporting the event. the reporter did not provide a causality assessment. Follow up 01/20/05: A follow up report was received on 04/16/02 stating that the patient, a 50 year ol female who had received Fluvirin on 11/02/01, had recovered from her general lack of wellbing, but was stil experiencing should pain in the left shoulder, which the reporter felt may be possible tendonitis, arm pain-tender over deltoid and bicept tendon, and exhibited a decreased range of movement. The patient was being trated with physiotherapy and NSAIDS. The painful swollen arm from the injection site reaction was still present. The reactions were still painful, although improved, on 04/10/02. The reporter has assesd the relationship of Fluvirin to the reactions as possible.
Why does it make my mother sick every year then?; Initial information received on 14-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves an unknown age female patient and it was reported that it make reporters mother sick every year (illness), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date it was reported that it make reporters mother sick every year (illness), while she received vaccine INFLUENZA VACCINE.   Other relevant tests included no lab data.  Final diagnosis was illness.  An unknown corrective treatment was received.  The event outcome was unknown.  There will be no information available on the batch number for this case.
pt recvd booster dose MMR on 15FEB91 & following vax exp pain in deltoid muscle & shoulder; pt was seen by surgeons who dx impingement synd; unable to raise arm above head; tenderness @ inject site;
After receiving the 2nd shot, had a moderate headache, significant tiredness, and light muscle fatigue that lasted for approximately 36 hours. No nausea.
Light headiness; Later had a rash; Fatigue; Body ache; Chills; Nausea; Vomiting; Headache severe; Had temperature of 101.7; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), HEADACHE (Headache severe) and PYREXIA (Had temperature of 101.7). At the time of the report, DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), HEADACHE (Headache severe) and PYREXIA (Had temperature of 101.7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.7 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: The email address was corrected on 14Jul2021.
Symptom started with an pain below the left ear. Pain worsened over time. Developed into partial Paralysis of the left side of the face.
Cellulitis at site of injection. Visited another facility on 7/4/15, treated with Rocephin 250 mg IM x 1 dose.
Fully vaccinated, not boosted.  Asymptomatic COVID breakthrough infection with inpatient hospital stay.
Fine after administration during the observation period.  At 7 or 7:30 pm patient started itching on face, back , arms and left leg.  patient says the itching was mild to moderate.  No visible rash.  Patient compared the itching to what happened after she took codeine.  Then throat started itching, no shortness of breath or difficulty breathing.  Eye also started watering.  At midnight the patient took a Benadryl and this help relieve the itching.  all the patient noticed was the injection site pain.  Today she is still itching, but it is mild and did not warrant Benadryl. Advised patient if she experiences any form of shortness of breath to go to the emergency room.
Moderna COVID-19 vaccine was administered to patients past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.  The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions
ROUGH NIGHTS SLEEP; DRY MOUTH; HEADCOLD; BREATHING ISSUES; SWEATING; FEVER; CHILLS; MILD HEADACHE; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included no alcohol use, and non smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient had drug abuse/illicit drug use. not necessarily takes cholesterol pill.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-MAR-2021 10:00 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced rough nights sleep. On MAR-2021, the subject experienced dry mouth. On MAR-2021, the subject experienced headcold. On MAR-2021, the subject experienced breathing issues. On MAR-2021, the subject experienced sweating. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced mild headache. Laboratory data included: Body temperature (NR: not provided) 99 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and chills on 12-MAR-2021, had not recovered from dry mouth, headcold, and breathing issues, and the outcome of rough nights sleep, mild headache and sweating was not reported. This report was non-serious.
Cellulitis of the left arm, Keflex 500mg 1 capsule four times daily, Prednisone 20 mg 2 tabs daily.
This spontaneous report was received from a physician via field representative refers to a 15 year old female patient. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were unknown. On an unknown date in 2011 (at her age of 11), the patient was vaccinated with first dose of GARDASIL 9 (anatomical location, dose, route, frequency, expiration date and lot number were not specified) as prophylaxis. Thereafter, the patient received her second and third dose on an unknown date in 2015 (reported as 4 years later) and in November 2015 respectively (inappropriate schedule of drug administration). In January 2016, the patient died (death) when she was 15 years old. It was unknown, if any lab diagnostics/studies were performed. The cause of death was unknown. It was unknown, if an autopsy was performed. The reporter did not assess the causality of the event death with GARDASIL 9. Product quality complaint was not involved.; Reported Cause(s) of Death: Unknown.
I contracted COVID-19 on 05/02/2022 with symptoms of severe headache, sore throat, sneezing , congestion, fever of 101, loss of appetite, chills, and severe fatigue. I was prescribed Paxlovid on 05/02/2022 and after finishing the Paxlovid on 05/10/2022 my symptoms were resolving. On 05/14/2022 I began feeling ill again, and my initial symptoms of sneezing, congestion, chest tightness, and fatigue returned. I developed a cough two weeks after initial illness and sought care at the urgent care. I was prescribed cough medicine and an albuterol inhaler upon my second visit to the urgent care. My symptoms have resolved except for a mild cough, fatigue, congestion, and chest tightness.  I still have not fully recovered as of today.
chronic urticaria,  polyarthritis, fatigue and muscle soreness-severe-- starting 10/29/2021 and ongoing.
LEFT ANTERIOLATERAL REDNESS AND SWELLING AT INJECTION SITE AND SURROUNDING AREA. 8CM IN DIAMETER. NO FEVER REPORTED
Tingling in feet and lower legs, numbness/tingling in left hand,  weakness/trembling in thighs/legs,  persistent headaches, appearance of very small blood spots under the skin, elevation of heart rate, unusually dry mouth and eyes upon waking, difficulty sleeping, significant fatigue.  These symptoms began about a week after the vaccination and persisted for approximately 6 weeks before seeing notable improvement.  As of today (10 weeks post vaccination) I am still experiencing tingling in my legs several days a week, however my headaches and fatigue have subsided.  I was evaluated by my PCP with a range of blood tests (all normal), and a neurologist who diagnosed my condition as vaccine induced neuropathy.